Dual-Color Fluorescence In Situ Hybridization Reveals an Association of Chromosome 8q22 but Not 8p21 Imbalance with High Grade Invasive Breast Carcinoma

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Walker, Logan C ^a   McDonald, Margaret ^a   Wells, J Elisabeth ^a   Harris, Gavin C ^b   Robinson, Bridget A ^a   Morris, Christine M ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INCIDENCE; CANCER SCREENING; CANCER SURVIVAL; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; NEEDLE BIOPSY; SCORING SYSTEM; TUMOR INVASION; VALIDATION PROCESS;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 8; DNA COPY NUMBER VARIATIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MASTECTOMY; MIDDLE AGED; NEOPLASM GRADING; SURVIVAL ANALYSIS; TRANSLOCATION, GENETIC;

EID: 84880771604     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070790     Document Type: Article

References (70)

1. Rakha EA, Ellis IO, (2011) Modern classification of breast cancer: should we stick with morphology or convert to molecular profile characteristics. Advances in anatomic pathology 18: 255-267.
2. Colombo PE, Milanezi F, Weigelt B, Reis-Filho JS, (2011) Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction. Breast Cancer Res 13: 212.
3. Cummings MC, Chambers R, Simpson PT, Lakhani SR, (2011) Molecular classification of breast cancer: is it time to pack up our microscopes? Pathology 43: 1-8.
4. Lee AH, Ellis IO, (2008) The Nottingham prognostic index for invasive carcinoma of the breast. Pathol Oncol Res 14: 113-115.
5. Elston CW, Ellis IO, (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410.
6. Komaki K, Sano N, Tangoku A, (2006) Problems in histological grading of malignancy and its clinical significance in patients with operable breast cancer. Breast Cancer 13: 249-253.
7. Paradiso A, Ellis IO, Zito FA, Marubini E, Pizzamiglio S, et al. (2009) Short- and long-term effects of a training session on pathologists' performance: the INQAT experience for histological grading in breast cancer. J Clin Pathol 62: 279-281.
8. Robbins P, Pinder S, de Klerk N, Dawkins H, Harvey J, et al. (1995) Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol 26: 873-879.
9. Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, et al. (1999) Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology. Virchows Arch 434: 3-10.
10. Staradub VL, Messenger KA, Hao N, Wiley EL, Morrow M, (2002) Changes in breast cancer therapy because of pathology second opinions. Ann Surg Oncol 9: 982-987.
11. Geyer FC, Marchio C, Reis-Filho JS, (2009) The role of molecular analysis in breast cancer. Pathology 41: 77-88.
12. Sotiriou C, Pusztai L, (2009) Gene-expression signatures in breast cancer. N Engl J Med 360: 790-800.
13. Allred DC, (2008) The utility of conventional and molecular pathology in managing breast cancer. Breast Cancer Res 10Suppl 4: S4.
14. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, et al. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821.
15. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, et al. (1997) Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20: 399-407.
16. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, et al. (1998) High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20: 207-211.
17. van Beers EH, Nederlof PM, (2006) Array-CGH and breast cancer. Breast Cancer Res 8: 210.
18. Reis-Filho JS, Simpson PT, Gale T, Lakhani SR, (2005) The molecular genetics of breast cancer: the contribution of comparative genomic hybridization. Pathol Res Pract 201: 713-725.
19. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, et al. (2002) Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A 99: 12963-12968.
20. Adelaide J, Finetti P, Bekhouche I, Repellini L, Geneix J, et al. (2007) Integrated profiling of basal and luminal breast cancers. Cancer Res 67: 11565-11575.
21. Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, et al. (2007) High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol 8: R215.
22. Haverty PM, Fridlyand J, Li L, Getz G, Beroukhim R, et al. (2008) High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer 47: 530-542.
23. Andre F, Job B, Dessen P, Tordai A, Michiels S, et al. (2009) Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res 15: 441-451.
24. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM,et al. (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature.
25. Ioannidis P, Mahaira L, Papadopoulou A, Teixeira MR, Heim S, et al. (2003) 8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas. Int J Cancer 104: 54-59.
26. Karlseder J, Zeillinger R, Schneeberger C, Czerwenka K, Speiser P, et al. (1994) Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer 9: 42-48.
27. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712.
28. Walker LC, Harris GC, Wells JE, Robinson BA, Morris CM, (2008) Association of chromosome band 8q22 copy number gain with high grade invasive breast carcinomas by assessment of core needle biopsies. Genes Chromosomes Cancer 47: 405-417.
29. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, et al. (1994) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A 91: 2156-2160.
30. Isola JJ, Kallioniemi OP, Chu LW, Fuqua SA, Hilsenbeck SG, et al. (1995) Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 147: 905-911.
31. Hermsen MA, Baak JP, Meijer GA, Weiss JM, Walboomers JW, et al. (1998) Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors. J Pathol 186: 356-362.
32. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, et al. (1998) Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 21: 177-184.
33. Buerger H, Otterbach F, Simon R, Schafer KL, Poremba C, et al. (1999) Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 189: 521-526.
34. Roylance R, Gorman P, Harris W, Liebmann R, Barnes D, et al. (1999) Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res 59: 1433-1436.
35. Loveday RL, Greenman J, Simcox DL, Speirs V, Drew PJ, et al. (2000) Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer 86: 494-500.
36. Richard F, Pacyna-Gengelbach M, Schluns K, Fleige B, Winzer KJ, et al. (2000) Patterns of chromosomal imbalances in invasive breast cancer. Int J Cancer 89: 305-310.
37. Buerger H, Mommers EC, Littmann R, Simon R, Diallo R, et al. (2001) Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol 194: 165-170.
38. Hislop RG, Pratt N, Stocks SC, Steel CM, Sales M, et al. (2002) Karyotypic aberrations of chromosomes 16 and 17 are related to survival in patients with breast cancer. Br J Surg 89: 1581-1586.
39. Rennstam K, Ahlstedt-Soini M, Baldetorp B, Bendahl PO, Borg A, et al. (2003) Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. Cancer Res 63: 8861-8868.
40. Weber-Mangal S, Sinn HP, Popp S, Klaes R, Emig R, et al. (2003) Breast cancer in young women (< or = 35 years): Genomic aberrations detected by comparative genomic hybridization. Int J Cancer 107: 583-592.
41. Janssen EA, Baak JP, Guervos MA, van Diest PJ, Jiwa M, et al. (2003) In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor. J Pathol 201: 555-561.
42. Farabegoli F, Hermsen MA, Ceccarelli C, Santini D, Weiss MM, et al. (2004) Simultaneous chromosome 1q gain and 16q loss is associated with steroid receptor presence and low proliferation in breast carcinoma. Mod Pathol 17: 449-455.
43. Loo LW, Grove DI, Williams EM, Neal CL, Cousens LA, et al. (2004) Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res 64: 8541-8549.
44. Naylor TL, Greshock J, Wang Y, Colligon T, Yu QC, et al. (2005) High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res 7: R1186-1198.
45. Yao J, Weremowicz S, Feng B, Gentleman RC, Marks JR, et al. (2006) Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res 66: 4065-4078.
46. Hicks J, Krasnitz A, Lakshmi B, Navin NE, Riggs M, et al. (2006) Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res 16: 1465-1479.
47. Bergamaschi A, Kim YH, Wang P, Sorlie T, Hernandez-Boussard T, et al. (2006) Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer 45: 1033-1040.
48. Han W, Jung EM, Cho J, Lee JW, Hwang KT, et al. (2008) DNA copy number alterations and expression of relevant genes in triple-negative breast cancer. Genes Chromosomes Cancer 47: 490-499.
49. Hwang KT, Han W, Cho J, Lee JW, Ko E, et al. (2008) Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer. Int J Cancer 123: 1807-1815.
50. Natrajan R, Lambros MB, Rodriguez-Pinilla SM, Moreno-Bueno G, Tan DS, et al. (2009) Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Clin Cancer Res 15: 2711-2722.
51. Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, et al. (2009) MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 15: 9-20.
52. Li Y, Zou L, Li Q, Haibe-Kains B, Tian R, et al. (2010) Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med 16: 214-218.
53. Cooke SL, Pole JC, Chin SF, Ellis IO, Caldas C, et al. (2008) High-resolution array CGH clarifies events occurring on 8p in carcinogenesis. BMC Cancer 8: 288.
54. Barnes DM, Harris WH, Smith P, Millis RR, Rubens RD, (1996) Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer 74: 1445-1451.
55. McCarty KS Jr, Miller LS, Cox EB, Konrath J, McCarty KS Sr, (1985) Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109: 716-721.
56. Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, et al. (2003) DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36: 361-374.
57. Dean AG, Sullivan KM, Soe MM OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.3.1. Available: www.OpenEpi.com.
58. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, et al. (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98: 262-272.
59. Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, et al. (1999) Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 187: 396-402.
60. Hwang ES, DeVries S, Chew KL, Moore DH 2nd, Kerlikowske K, et al. (2004) Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin Cancer Res 10: 5160-5167.
61. Vos CB, ter Haar NT, Rosenberg C, Peterse JL, Cleton-Jansen AM, et al. (1999) Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type. Br J Cancer 81: 1410-1418.
62. Vincent-Salomon A, Lucchesi C, Gruel N, Raynal V, Pierron G, et al. (2008) Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast. Clin Cancer Res 14: 1956-1965.
63. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR, (2005) Molecular evolution of breast cancer. J Pathol 205: 248-254.
64. Korsching E, Packeisen J, Helms MW, Kersting C, Voss R, et al. (2004) Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry. Br J Cancer 90: 1422-1428.
65. Roylance R, Gorman P, Papior T, Wan YL, Ives M, et al. (2006) A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH. Oncogene 25: 6544-6553.
66. Armes JE, Hammet F, de Silva M, Ciciulla J, Ramus SJ, et al. (2004) Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers. Oncogene 23: 5697-5702.
67. Loo LW, Ton C, Wang YW, Grove DI, Bouzek H, et al. (2008) Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer. Genes Chromosomes Cancer 47: 1049-1066.
68. Rummukainen J, Kytola S, Karhu R, Farnebo F, Larsson C, et al. (2001) Aberrations of chromosome 8 in 16 breast cancer cell lines by comparative genomic hybridization, fluorescence in situ hybridization, and spectral karyotyping. Cancer Genet Cytogenet 126: 1-7.
69. Kytola S, Rummukainen J, Nordgren A, Karhu R, Farnebo F, et al. (2000) Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping. Genes Chromosomes Cancer 28: 308-317.
70. Davidson JM, Gorringe KL, Chin SF, Orsetti B, Besret C, et al. (2000) Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer 83: 1309-1317.